Comprehensive medication guide to Apixaban including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$10–$50 copay for most plans; typically Tier 1-2 for generic, Tier 3 for brand, prior authorization sometimes required
Estimated Cash Pricing
$500–$600 retail for brand Eliquis; $30–$80 for generic Apixaban; Medicare Maximum Fair Price $231/month (effective Jan 2026)
Medfinder Findability Score
60/100
Summarize with AI
On this page
Apixaban (brand name Eliquis) is a prescription blood thinner in the class of Direct Oral Anticoagulants (DOACs). It's used to prevent stroke and blood clots in patients with atrial fibrillation, treat deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevent blood clots after hip or knee replacement surgery. Unlike older blood thinners like Warfarin, Apixaban doesn't require regular blood monitoring or strict dietary restrictions.
Important 2026 update: Apixaban (Eliquis) was selected for Medicare Part D price negotiations under the Inflation Reduction Act. The negotiated Maximum Fair Price of $231 for a 30-day supply took effect January 1, 2026, significantly reducing costs for Medicare beneficiaries.
![Why Is Apixaban So Hard to Find? [Explained for 2026]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2F56c9ec0eb055888aafbf001d52a932061226dfa2-1024x1024.png%3Frect%3D0%2C256%2C1024%2C512%26w%3D400%26h%3D200%26auto%3Dformat&w=828&q=75)
![How to Find a Doctor Who Can Prescribe Apixaban Near You [2026 Guide]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2F50d93de9b57f39736f3fe973d1679609b002655b-1024x1024.png%3Frect%3D0%2C256%2C1024%2C512%26w%3D400%26h%3D200%26auto%3Dformat&w=828&q=75)
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Apixaban works by selectively blocking Factor Xa, a key enzyme in the blood clotting cascade. By inhibiting Factor Xa, it prevents the conversion of prothrombin to thrombin, which reduces the formation of blood clots without completely stopping the body's ability to clot when necessary. This targeted approach makes it effective at preventing harmful clots while minimizing bleeding risk compared to older anticoagulants.
2.5 mg oral tablets
for reduced dosing in atrial fibrillation patients or DVT prophylaxis after hip/knee surgery
5 mg oral tablets
standard dose for most indications including atrial fibrillation, DVT, and PE treatment
Generic Apixaban became available in late 2024/early 2025 after patent settlements, creating initial supply disruptions as pharmacies transitioned from brand Eliquis to multiple generic manufacturers. As of 2026, supply has significantly improved with increasing competition from multiple generic producers driving both availability and prices down.
The Medicare price negotiations that took effect in January 2026 have also stabilized supply chains, as manufacturers adjusted to new pricing structures. While some patients may still occasionally encounter specific generic formulations being temporarily out of stock at individual pharmacies, overall availability has improved markedly compared to the transition period in 2025.
Brand Eliquis remains consistently available but is more expensive than generic alternatives, though Medicare patients now benefit from the negotiated Maximum Fair Price of $231 per month.
Apixaban can be prescribed by various specialists and primary care providers, including cardiologists, hematologists, internal medicine doctors, family medicine physicians, vascular medicine specialists, and emergency medicine doctors. Orthopedic surgeons also commonly prescribe it for post-surgical blood clot prevention. Many providers are comfortable prescribing DOACs like Apixaban due to their predictable effects and reduced monitoring requirements.
No, Apixaban is not a controlled substance and has no DEA schedule classification. It's a prescription medication that requires a doctor's order but doesn't have the additional regulatory restrictions that apply to controlled substances like opioids or stimulants.
Know what you need? Skip the search.
Rivaroxaban (Xarelto)
Another Factor Xa inhibitor with once-daily dosing for most indications
Warfarin (Coumadin)
Older anticoagulant requiring regular blood monitoring but much less expensive
Edoxaban (Savaysa)
Factor Xa inhibitor with once-daily dosing, requires initial injectable anticoagulation for blood clots
Dabigatran (Pradaxa)
Direct thrombin inhibitor with twice-daily dosing and a specific reversal agent available
Prefer Apixaban? We can find it.
Strong CYP3A4 inhibitors
moderateKetoconazole, Ritonavir, Clarithromycin increase Apixaban levels, requiring dose reduction
Strong CYP3A4 inducers
moderateRifampin, Carbamazepine, St. John's Wort decrease effectiveness, should be avoided
Other blood thinners
moderateWarfarin, Heparin, Enoxaparin significantly increase bleeding risk
NSAIDs
moderateIbuprofen, Naproxen, Aspirin increase bleeding risk when used together
Antidepressants
moderateSSRIs and SNRIs may modestly increase bleeding risk
Apixaban represents a significant advance in anticoagulation therapy, offering effective clot prevention without the dietary restrictions and monitoring requirements of older medications like Warfarin. The recent availability of generic versions has made it more affordable, though supply transitions may cause temporary availability issues at some pharmacies. Patients should work closely with their healthcare providers to determine if Apixaban is right for their condition and to monitor for any signs of bleeding or other side effects. If you're having trouble finding Apixaban in stock, Medfinder can help locate pharmacies with current inventory.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards
ChatGPT
Claude
Perplexity
Grok
Gemini